Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2023-03-09 00:00:00 ET · period of report 2023-03-09 · accession 0001228924-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-09 | 2023-03-09 | MLAB | Sakys John | CFO | M - OptEx | $70.56 | +400 | 10.1K | +4% | +$28.2K |
| D | 2023-03-09 | 2023-03-09 | MLAB | Sakys John | CFO | S - Sale+OE | $169.97 | -400 | 9,696 | -4% | -$68.0K |
| D | 2023-03-09 | 2023-03-09 | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -400 | 26.3K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-09 | M | A | 400 | $70.56 | 10,096 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-09 | S | D | 400 | $169.97 | 9,696 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 14, 2022 |
| 3 | Derivative | Incentive Stock Option | 2023-03-09 | X | D | 400 | $0.00 | 26,302 | D | $70.56 · 2016-04-01 to 2023-04-01 | 400 Common Stock | (F1) 1/7 exercisable on each anniversary date of the 04/01/2015 grant date |